
Synthecis Pharmaceuticals Private Limited
Manufacturing and trading of pharmaceuticals, healthcare products, and chemicals for various industries.
Manufacturing and trading of pharmaceuticals, healthcare products, and chemicals for various industries.
Synthecis Pharmaceuticals Private Limited (SPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 15 October 2019 (Five years and four months 18 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.80 Cr.
Sri Vetukuri and Gande Deepthi serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
-
U24233TG2019PTC136091
136091
Private Limited Indian Non-Government Company
15 Oct 2019
02 Aug 2023
31 Mar 2023
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sri Vetukuri ![]() | Director | 15-Oct-2019 | Current |
Gande Deepthi ![]() | Director | 27-Oct-2021 | Current |
Synthecis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.85% decrease. The company also saw a substantial improvement in profitability, with a 36.96% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.34%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Synthecis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹18.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
16 Dec 2020 | Bank Of India | ₹1.80 Cr | Open |
Synthecis Pharmaceuticals has a workforce of 10 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synthecis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthecis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Synthecis Pharmaceuticals Private Limited last Annual general meeting of members was held on 02 Aug 2023 as per latest MCA records.
Synthecis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Gande Deepthi was appointed as a Director was appointed as a Director on 27 Oct 2021 & has been associated with this company since 3 years 4 months .
A charge with Bank Of India amounted to Rs. 18.00 M with Charge ID 100431189 was registered on 16 Dec 2020.
Sri Vidya Vetukuri was appointed as a Director was appointed as a Director on 15 Oct 2019 & has been associated with this company since 5 years 4 months .
Synthecis Pharmaceuticals Private Limited was registered on 15 Oct 2019 with Roc Hyderabad & aged 5 years 4 months as per MCA records.
Synthecis Pharmaceuticals Private Limited was incorporated on 15 Oct 2019.
The authorized share capital of Synthecis Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Synthecis Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Synthecis Pharmaceuticals Private Limited is Block B4 Flat No.301 Meadow Land Apartments Cbcid Colony Bhagathsingh Nagar, Phase 2 India, Hyderabad, Telangana, 500072.
The corporate identification number (CIN) of Synthecis Pharmaceuticals Private Limited is U24233TG2019PTC136091 and the company number is 136091 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Synthecis Pharmaceuticals Private Limited has fallen by -99.85%.
As Per 2023 financial reports, 10 employees are currently employed by Synthecis Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Synthecis Pharmaceuticals Private Limited has experienced an downturn of -16.34%.
As per the financial statements for fiscal Year 2023, The total open charges for Synthecis Pharmaceuticals Private Limited amount to ₹ 1.80 Cr.
The most recent Balance Sheet for Synthecis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
RR